A Localized Aldara (5% Imiquimod)-Induced Psoriasiform Dermatitis Model in Mice Using Finn Chambers.

Area of Science:

• Dermatology
• Immunology
• Preclinical Research

Background:

• The imiquimod-induced psoriasiform dermatitis model is valuable for skin research.
• Systemic inflammation and adverse effects are limitations of current imiquimod models.
• Standardized protocols are needed to improve reproducibility and reduce variability.

Purpose of the Study:

• To present a refined protocol for inducing psoriasiform dermatitis using Finn chambers.
• To reduce systemic toxicity associated with imiquimod cream application.
• To enhance the reliability and reproducibility of preclinical skin disease models.

Main Methods:

• Utilizing Finn chambers to localize imiquimod cream application to small skin areas.
• Implementing concurrent control and experimental skin sites on the same animal.
• Performing functional measurements including skin thickness, blood perfusion, and histopathology.

Main Results:

• Localized imiquimod application induced severe, reproducible psoriatic skin reactions.
• Systemic side effects such as splenomegaly and mortality were significantly reduced.
• Reduced inter-animal variability was observed due to paired skin site comparisons.

Conclusions:

• Finn chamber application offers a safer and more effective method for imiquimod-induced psoriasiform dermatitis.
• This protocol enhances the utility of mouse models for studying inflammatory skin diseases.
• The methodology is adaptable for other topical agent-based skin disease models.